Is It Worth Investing in Oracle (ORCL) Based on Wall Street's Bullish Views?

31.10.24 14:30 Uhr

Werte in diesem Artikel
Aktien

161,48 EUR -2,12 EUR -1,30%

Indizes

PKT PKT

20.031,1 PKT 266,2 PKT 1,35%

2.978,5 PKT 35,7 PKT 1,21%

6.040,0 PKT 66,0 PKT 1,10%

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Oracle (ORCL) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Oracle currently has an average brokerage recommendation (ABR) of 1.77, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 31 brokerage firms. An ABR of 1.77 approximates between Strong Buy and Buy.Of the 31 recommendations that derive the current ABR, 19 are Strong Buy, representing 61.3% of all recommendations.Brokerage Recommendation Trends for ORCLCheck price target & stock forecast for Oracle here>>>While the ABR calls for buying Oracle, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near -term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.ABR Should Not Be Confused With Zacks RankAlthough both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.Is ORCL a Good Investment?Looking at the earnings estimate revisions for Oracle, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $6.20.Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Oracle. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Oracle.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oracle Corporation (ORCL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Oracle

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Oracle

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Oracle Corp.

Analysen zu Oracle Corp.

DatumRatingAnalyst
10.12.2024Oracle HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.12.2024Oracle Sector PerformRBC Capital Markets
10.12.2024Oracle NeutralJP Morgan Chase & Co.
10.12.2024Oracle BuyUBS AG
10.12.2024Oracle BuyJefferies & Company Inc.
DatumRatingAnalyst
10.12.2024Oracle BuyUBS AG
10.12.2024Oracle BuyJefferies & Company Inc.
05.12.2024Oracle BuyJefferies & Company Inc.
30.09.2024Oracle KaufenDZ BANK
25.09.2024Oracle BuyUBS AG
DatumRatingAnalyst
10.12.2024Oracle HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.12.2024Oracle Sector PerformRBC Capital Markets
10.12.2024Oracle NeutralJP Morgan Chase & Co.
23.10.2024Oracle Sector PerformRBC Capital Markets
07.10.2024Oracle HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
13.12.2022Oracle SellGoldman Sachs Group Inc.
21.10.2022Oracle SellGoldman Sachs Group Inc.
19.03.2019Oracle VerkaufenDZ BANK
17.09.2015Oracle SellJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
08.01.2015Oracle SellJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Oracle Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"